No pharmaceutical industry blackout
Pharmaceutical companies maintained "critical" business operations during a blackout affecting parts of the Northeast and Midwest on Aug. 14 and 15. Pfizer said it implemented its "snow day" plan, meaning only "critical users" reported to the company's R&D headquarters in Groton, Conn. and an Ann Arbor, Mich. facility. Diesel generators supplied power to both facilities, keeping critical manufacturing and "temperature specific" experiments operational. Pfizer's Manhattan headquarters was closed Aug. 15. Novartis and Roche, both with U.S. operations headquartered in New Jersey, said R&D and manufacturing maintained "full capacity" both days. Merck and Schering-Plough both said their New Jersey facilities were not affected by the power outages...
You may also be interested in...
The top-line data in the ultra-rare disease are also the first to demonstrate safety and efficacy of an RNAi therapy in patients six years and younger.
Bayer notes “significant headwinds" from pandemic hitting its 2020 results likely will continue in 2021, when it t expects core earnings per share slightly below 2020 levels. While noting slumping revenues across its divisions, Bayer said an exception its consumer health business.
After US President Trump said vaccine developers could develop a COVID-19 vaccine faster if it weren't for politics, Moderna CEO Bancel said no political party has asked the company to move faster or slower.